Nixon Peabody Trust CO Bristol Myers Squibb CO Transaction History

Nixon Peabody Trust CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $196,537 - $234,523	4,054 New	4,054 $208,000
Q2 2023 Jul 27, 2023	SELL	$63.71 - $70.74 $662,074 - $735,130	-10,392 Reduced 33.63%	20,510 $1.31 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $2,891 - $3,279	44 Added 0.14%	30,902 $2.14 Million
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $964,061 - $1.14 Million	14,078 Added 83.9%	30,858 $2.22 Million
Q3 2022 Mar 15, 2023	SELL	$0.13 - $76.84 $81 - $48,025	-625 Reduced 2.03%	30,233 $2.15 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $2,216 - $1.31 Million	-17,049 Reduced 50.4%	16,780 $1.19 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $1.13 Million - $1.24 Million	15,561 Added 85.18%	33,829 $2.61 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $743,723 - $891,790	12,097 Added 196.03%	18,268 $1.33 Million
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $330,950 - $385,810	6,171 New	6,171 $385,000
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $219,280 - $256,360	-4,000 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$46.4 - $67.43 $185,600 - $269,720	4,000 New	4,000 $223,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Nixon Peabody Trust CO, based on Form 13F filings with the SEC.

Stay updated on Nixon Peabody Trust CO with notifications on news.